Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d798391c73077bfa39f7cf680fa8961 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7610f737c4f5dfede3154f3086f8064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c68a05a09be48306a1e277fb72455112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19e923f8e1bef7e990854a54005d98d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b765b53e6651e9863a3a35e4c1e164 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0093 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
filingDate |
2012-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d711fe2401da8f05069a3eb8b5060c2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16033db6c1fb250088a1ae4824f193bb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0274642109f07f02f4fcb2a76aea6584 |
publicationDate |
2013-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8383082-B1 |
titleOfInvention |
Pharmaceutical composition of nanoparticles |
abstract |
The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020028907-A1 |
priorityDate |
2005-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |